Pure Biologics S.A. (WSE:PUR)
Poland · Delayed Price · Currency is PLN 3.584
-0.016 (-0.44%)
At close: Feb 12, 2026
Pure Biologics Market Cap
Pure Biologics has a market cap or net worth of 43.89 million as of February 12, 2026. Its market cap has decreased by -29.64% in one year.
Market Cap
43.89M
Enterprise Value
58.75M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.58
Market Cap Chart
Since December 11, 2018, Pure Biologics's market cap has increased from 26.85M to 43.89M, an increase of 63.46%. That is a compound annual growth rate of 7.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 43.89M | 50.93% |
| Dec 30, 2025 | 29.08M | -54.90% |
| Dec 30, 2024 | 64.47M | 53.27% |
| Dec 29, 2023 | 42.06M | -18.86% |
| Dec 30, 2022 | 51.84M | -70.44% |
| Dec 30, 2021 | 175.36M | -4.91% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ryvu Therapeutics | 593.03M |
| Captor Therapeutics Spolka Akcyjna | 461.09M |
| Bioceltix | 411.19M |
| BIOTON | 339.16M |
| Synthaverse | 266.45M |
| Molecure | 151.43M |
| Mabion | 132.21M |
| Poltreg | 124.05M |